|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 | (2006.01) |
| A61K 38/4846 | (2013.01) | ||
| C12N 15/55 | (2006.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61K 38/43 | (2006.01) | ||
| C12N 9/644 | (2013.01) | ||
| C12Y 304/21022 | (2013.01) |
| (11) | Patento numeris | 3663399 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19218636.9 |
| Europos patento paraiškos padavimo data | 2011-11-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 45629810 P | 2010-11-03 | US |
| (72) |
MADISON, Edwin L , US
THANOS, Christopher , US
BLOUSE, Grant Ellsworth , US
|
| (73) |
Catalyst Biosciences, Inc. ,
611 Gateway Blvd., Suite 710, South San Francisco, CA 94080,
US
|
| (54) | MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |
| MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF |